Bristol-Myers Squibb: Arthritis, Psoriatic trials

The registry lists 12 Arthritis, Psoriatic studies with Bristol-Myers Squibb as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 3Phase 2 2Phase 3 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study CompletersNot yet recruitingNCT07791199Phase 3
• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic DrugsActive, not recruitingNCT04908202Phase 3Results posted
• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor TreatmentActive, not recruitingNCT04908189Phase 3Results posted
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)CompletedNCT03881059Phase 2Results posted
• Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic ArthritisCompletedNCT01860976Phase 3Results posted
• Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic ArthritisTerminatedNCT00534313Phase 2Results posted
• A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish DatabaseCompletedNCT05421442
• A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) RegisterCompletedNCT05413044
• Safety and Effectiveness of Abatacept in Psoriatic Arthritis ParticipantsCompletedNCT03419143
• A Study to Investigate BMS-986165 and Methotrexate in Healthy Male PatientsCompletedNCT03402087Phase 1
• The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female PatientsCompletedNCT03262727Phase 1
• A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet FormulationCompletedNCT03254784Phase 1